Capital City Bank Group, Inc. Reports First Quarter 2024 Results
April 22, 2024 07:00 ET
|
Capital City Bank Group
TALLAHASSEE, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $12.6 million, or $0.74 per diluted...
Greenbacker Development Opportunities Releases 2023 Impact Report
April 22, 2024 07:00 ET
|
Greenbacker Capital Management LLC
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- The Greenbacker Development Opportunities Funds (collectively, “GDEV”), investment vehicles affiliated with Greenbacker Capital Management...
Marquette National Corporation Declares a Dividend of $0.28 per Share
April 22, 2024 07:00 ET
|
Marquette Bank
Marquette National Corporation Declares a Dividend of $0.28 per Share
DAVIDsTEA Deepens Sustainability Commitment and Introduces New Compostable Packaging
April 22, 2024 07:00 ET
|
DAVIDsTEA
The brand’s Garden to Cup tea collection is re-imagined with earth in mind featuring new compostable loose leaf tea packaging MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- DAVIDsTEA Inc....
Comscore to Announce First Quarter 2024 Financial Results
April 22, 2024 07:00 ET
|
Comscore, Inc.
RESTON, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference...
Bonaccord Capital Partners Announces Strategic Minority Investment in Lead Edge Capital
April 22, 2024 07:00 ET
|
Bonaccord Capital Advisors
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bonaccord Capital Partners (“Bonaccord”), a private equity business focused on providing growth capital to exceptional mid-market private markets...
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 22, 2024 07:00 ET
|
Passage Bio
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative...
Loratadine Market to Garner $221.4 Billion, Globally, by 2033 at 3.1% CAGR: The Brainy Insights
April 22, 2024 07:00 ET
|
The Brainy Insights
Newark, April 22, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 163.2 billion loratadine market will reach USD 221.4 billion by 2033. Loratadine is an antihistamine drug. All...
Verizon begins 2024 with strong wireless service revenue growth, solid cash flow and continued momentum in broadband
April 22, 2024 07:00 ET
|
Verizon Sourcing LLC
Verizon begins 2024 with strong wireless service revenue growth, solid cash flow and continued momentum in broadband
Bonterra Announces Upsize of Brokered Private Placement to Approximately $7.8 Million
April 22, 2024 07:00 ET
|
Bonterra Resources Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VAL-D'OR,...
- September 20, 2024 13:45 ET ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
- September 20, 2024 12:59 ET L’Arche Vancouver opens new $37-Million Dream Home